1 Recombinant Human Thrombopoietin (rhTPO) Market Overview 1.1 Product Overview and Scope of Recombinant Human Thrombopoietin (rhTPO) 1.2 Recombinant Human Thrombopoietin (rhTPO) Segment by Type 1.2.1 Global Recombinant Human Thrombopoietin (rhTPO) Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 rhTPO 1.2.3 Fusion Protein 1.3 Recombinant Human Thrombopoietin (rhTPO) Segment by Application 1.3.1 Global Recombinant Human Thrombopoietin (rhTPO) Sales Comparison by Application: (2021-2027) 1.3.2 Medication 1.3.3 Scientific Research 1.4 Global Recombinant Human Thrombopoietin (rhTPO) Market Size Estimates and Forecasts 1.4.1 Global Recombinant Human Thrombopoietin (rhTPO) Revenue 2016-2027 1.4.2 Global Recombinant Human Thrombopoietin (rhTPO) Sales 2016-2027 1.4.3 Recombinant Human Thrombopoietin (rhTPO) Market Size by Region: 2016 Versus 2021 Versus 2027 2 Recombinant Human Thrombopoietin (rhTPO) Market Competition by Manufacturers 2.1 Global Recombinant Human Thrombopoietin (rhTPO) Sales Market Share by Manufacturers (2016-2021) 2.2 Global Recombinant Human Thrombopoietin (rhTPO) Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Recombinant Human Thrombopoietin (rhTPO) Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Recombinant Human Thrombopoietin (rhTPO) Manufacturing Sites, Area Served, Product Type 2.5 Recombinant Human Thrombopoietin (rhTPO) Market Competitive Situation and Trends 2.5.1 Recombinant Human Thrombopoietin (rhTPO) Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Recombinant Human Thrombopoietin (rhTPO) Players Market Share by Revenue 2.5.3 Global Recombinant Human Thrombopoietin (rhTPO) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Recombinant Human Thrombopoietin (rhTPO) Retrospective Market Scenario by Region 3.1 Global Recombinant Human Thrombopoietin (rhTPO) Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Recombinant Human Thrombopoietin (rhTPO) Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Recombinant Human Thrombopoietin (rhTPO) Market Facts & Figures by Country 3.3.1 North America Recombinant Human Thrombopoietin (rhTPO) Sales by Country 3.3.2 North America Recombinant Human Thrombopoietin (rhTPO) Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Recombinant Human Thrombopoietin (rhTPO) Market Facts & Figures by Country 3.4.1 Europe Recombinant Human Thrombopoietin (rhTPO) Sales by Country 3.4.2 Europe Recombinant Human Thrombopoietin (rhTPO) Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Recombinant Human Thrombopoietin (rhTPO) Market Facts & Figures by Region 3.5.1 Asia Pacific Recombinant Human Thrombopoietin (rhTPO) Sales by Region 3.5.2 Asia Pacific Recombinant Human Thrombopoietin (rhTPO) Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Recombinant Human Thrombopoietin (rhTPO) Market Facts & Figures by Country 3.6.1 Latin America Recombinant Human Thrombopoietin (rhTPO) Sales by Country 3.6.2 Latin America Recombinant Human Thrombopoietin (rhTPO) Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Recombinant Human Thrombopoietin (rhTPO) Market Facts & Figures by Country 3.7.1 Middle East and Africa Recombinant Human Thrombopoietin (rhTPO) Sales by Country 3.7.2 Middle East and Africa Recombinant Human Thrombopoietin (rhTPO) Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Recombinant Human Thrombopoietin (rhTPO) Historic Market Analysis by Type 4.1 Global Recombinant Human Thrombopoietin (rhTPO) Sales Market Share by Type (2016-2021) 4.2 Global Recombinant Human Thrombopoietin (rhTPO) Revenue Market Share by Type (2016-2021) 4.3 Global Recombinant Human Thrombopoietin (rhTPO) Price by Type (2016-2021) 5 Global Recombinant Human Thrombopoietin (rhTPO) Historic Market Analysis by Application 5.1 Global Recombinant Human Thrombopoietin (rhTPO) Sales Market Share by Application (2016-2021) 5.2 Global Recombinant Human Thrombopoietin (rhTPO) Revenue Market Share by Application (2016-2021) 5.3 Global Recombinant Human Thrombopoietin (rhTPO) Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Qilu Pharmaceutical 6.1.1 Qilu Pharmaceutical Corporation Information 6.1.2 Qilu Pharmaceutical Description and Business Overview 6.1.3 Qilu Pharmaceutical Recombinant Human Thrombopoietin (rhTPO) Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Qilu Pharmaceutical Recombinant Human Thrombopoietin (rhTPO) Product Portfolio 6.1.5 Qilu Pharmaceutical Recent Developments/Updates 6.2 R&D Systems 6.2.1 R&D Systems Corporation Information 6.2.2 R&D Systems Description and Business Overview 6.2.3 R&D Systems Recombinant Human Thrombopoietin (rhTPO) Sales, Revenue and Gross Margin (2016-2021) 6.2.4 R&D Systems Recombinant Human Thrombopoietin (rhTPO) Product Portfolio 6.2.5 R&D Systems Recent Developments/Updates 6.3 Merck 6.3.1 Merck Corporation Information 6.3.2 Merck Description and Business Overview 6.3.3 Merck Recombinant Human Thrombopoietin (rhTPO) Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Merck Recombinant Human Thrombopoietin (rhTPO) Product Portfolio 6.3.5 Merck Recent Developments/Updates 6.4 Shionogi 6.4.1 Shionogi Corporation Information 6.4.2 Shionogi Description and Business Overview 6.4.3 Shionogi Recombinant Human Thrombopoietin (rhTPO) Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Shionogi Recombinant Human Thrombopoietin (rhTPO) Product Portfolio 6.4.5 Shionogi Recent Developments/Updates 6.5 MedChemExpress 6.5.1 MedChemExpress Corporation Information 6.5.2 MedChemExpress Description and Business Overview 6.5.3 MedChemExpress Recombinant Human Thrombopoietin (rhTPO) Sales, Revenue and Gross Margin (2016-2021) 6.5.4 MedChemExpress Recombinant Human Thrombopoietin (rhTPO) Product Portfolio 6.5.5 MedChemExpress Recent Developments/Updates 6.6 PeproTech 6.6.1 PeproTech Corporation Information 6.6.2 PeproTech Description and Business Overview 6.6.3 PeproTech Recombinant Human Thrombopoietin (rhTPO) Sales, Revenue and Gross Margin (2016-2021) 6.6.4 PeproTech Recombinant Human Thrombopoietin (rhTPO) Product Portfolio 6.6.5 PeproTech Recent Developments/Updates 6.7 Kelun 6.6.1 Kelun Corporation Information 6.6.2 Kelun Description and Business Overview 6.6.3 Kelun Recombinant Human Thrombopoietin (rhTPO) Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Kelun Recombinant Human Thrombopoietin (rhTPO) Product Portfolio 6.7.5 Kelun Recent Developments/Updates 7 Recombinant Human Thrombopoietin (rhTPO) Manufacturing Cost Analysis 7.1 Recombinant Human Thrombopoietin (rhTPO) Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Recombinant Human Thrombopoietin (rhTPO) 7.4 Recombinant Human Thrombopoietin (rhTPO) Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Recombinant Human Thrombopoietin (rhTPO) Distributors List 8.3 Recombinant Human Thrombopoietin (rhTPO) Customers 9 Recombinant Human Thrombopoietin (rhTPO) Market Dynamics 9.1 Recombinant Human Thrombopoietin (rhTPO) Industry Trends 9.2 Recombinant Human Thrombopoietin (rhTPO) Growth Drivers 9.3 Recombinant Human Thrombopoietin (rhTPO) Market Challenges 9.4 Recombinant Human Thrombopoietin (rhTPO) Market Restraints 10 Global Market Forecast 10.1 Recombinant Human Thrombopoietin (rhTPO) Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Recombinant Human Thrombopoietin (rhTPO) by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Recombinant Human Thrombopoietin (rhTPO) by Type (2022-2027) 10.2 Recombinant Human Thrombopoietin (rhTPO) Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Recombinant Human Thrombopoietin (rhTPO) by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Recombinant Human Thrombopoietin (rhTPO) by Application (2022-2027) 10.3 Recombinant Human Thrombopoietin (rhTPO) Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Recombinant Human Thrombopoietin (rhTPO) by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Recombinant Human Thrombopoietin (rhTPO) by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Recombinant Human Thrombopoietin (rhTPO) Sales (KG) Growth Rate Comparison by Type (2021-2027) Table 2. Global Recombinant Human Thrombopoietin (rhTPO) Sales (KG) Comparison by Application (2021-2027) Table 3. Global Recombinant Human Thrombopoietin (rhTPO) Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Recombinant Human Thrombopoietin (rhTPO) Covered in This Study Table 5. Global Recombinant Human Thrombopoietin (rhTPO) Sales (KG) of Key Manufacturers (2016-2021) Table 6. Global Recombinant Human Thrombopoietin (rhTPO) Sales Market Share by Manufacturers (2016-2021) Table 7. Global Recombinant Human Thrombopoietin (rhTPO) Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Recombinant Human Thrombopoietin (rhTPO) Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Recombinant Human Thrombopoietin (rhTPO) Average Price (USD/g) of Key Manufacturers (2016-2021) Table 10. Manufacturers Recombinant Human Thrombopoietin (rhTPO) Manufacturing Sites and Area Served Table 11. Manufacturers Recombinant Human Thrombopoietin (rhTPO) Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Recombinant Human Thrombopoietin (rhTPO) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Human Thrombopoietin (rhTPO) as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Recombinant Human Thrombopoietin (rhTPO) Sales by Region (2016-2021) & (KG) Table 16. Global Recombinant Human Thrombopoietin (rhTPO) Sales Market Share by Region (2016-2021) Table 17. Global Recombinant Human Thrombopoietin (rhTPO) Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Recombinant Human Thrombopoietin (rhTPO) Sales by Country (2016-2021) & (KG) Table 19. North America Recombinant Human Thrombopoietin (rhTPO) Sales Market Share by Country (2016-2021) Table 20. North America Recombinant Human Thrombopoietin (rhTPO) Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Recombinant Human Thrombopoietin (rhTPO) Revenue Market Share by Country (2016-2021) Table 22. Europe Recombinant Human Thrombopoietin (rhTPO) Sales by Country (2016-2021) & (KG) Table 23. Europe Recombinant Human Thrombopoietin (rhTPO) Sales Market Share by Country (2016-2021) Table 24. Europe Recombinant Human Thrombopoietin (rhTPO) Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Recombinant Human Thrombopoietin (rhTPO) Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Recombinant Human Thrombopoietin (rhTPO) Sales by Region (2016-2021) & (KG) Table 27. Asia Pacific Recombinant Human Thrombopoietin (rhTPO) Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Recombinant Human Thrombopoietin (rhTPO) Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Recombinant Human Thrombopoietin (rhTPO) Revenue Market Share by Region (2016-2021) Table 30. Latin America Recombinant Human Thrombopoietin (rhTPO) Sales by Country (2016-2021) & (KG) Table 31. Latin America Recombinant Human Thrombopoietin (rhTPO) Sales Market Share by Country (2016-2021) Table 32. Latin America Recombinant Human Thrombopoietin (rhTPO) Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Recombinant Human Thrombopoietin (rhTPO) Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Recombinant Human Thrombopoietin (rhTPO) Sales by Country (2016-2021) & (KG) Table 35. Middle East and Africa Recombinant Human Thrombopoietin (rhTPO) Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Recombinant Human Thrombopoietin (rhTPO) Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Recombinant Human Thrombopoietin (rhTPO) Revenue Market Share by Country (2016-2021) Table 38. Global Recombinant Human Thrombopoietin (rhTPO) Sales (KG) by Type (2016-2021) Table 39. Global Recombinant Human Thrombopoietin (rhTPO) Sales Market Share by Type (2016-2021) Table 40. Global Recombinant Human Thrombopoietin (rhTPO) Revenue (Million US$) by Type (2016-2021) Table 41. Global Recombinant Human Thrombopoietin (rhTPO) Revenue Share by Type (2016-2021) Table 42. Global Recombinant Human Thrombopoietin (rhTPO) Price (USD/g) by Type (2016-2021) Table 43. Global Recombinant Human Thrombopoietin (rhTPO) Sales (KG) by Application (2016-2021) Table 44. Global Recombinant Human Thrombopoietin (rhTPO) Sales Market Share by Application (2016-2021) Table 45. Global Recombinant Human Thrombopoietin (rhTPO) Revenue (Million US$) by Application (2016-2021) Table 46. Global Recombinant Human Thrombopoietin (rhTPO) Revenue Share by Application (2016-2021) Table 47. Global Recombinant Human Thrombopoietin (rhTPO) Price (USD/g) by Application (2016-2021) Table 48. Qilu Pharmaceutical Corporation Information Table 49. Qilu Pharmaceutical Description and Business Overview Table 50. Qilu Pharmaceutical Recombinant Human Thrombopoietin (rhTPO) Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021) Table 51. Qilu Pharmaceutical Recombinant Human Thrombopoietin (rhTPO) Product Table 52. Qilu Pharmaceutical Recent Developments/Updates Table 53. R&D Systems Corporation Information Table 54. R&D Systems Description and Business Overview Table 55. R&D Systems Recombinant Human Thrombopoietin (rhTPO) Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021) Table 56. R&D Systems Recombinant Human Thrombopoietin (rhTPO) Product Table 57. R&D Systems Recent Developments/Updates Table 58. Merck Corporation Information Table 59. Merck Description and Business Overview Table 60. Merck Recombinant Human Thrombopoietin (rhTPO) Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021) Table 61. Merck Recombinant Human Thrombopoietin (rhTPO) Product Table 62. Merck Recent Developments/Updates Table 63. Shionogi Corporation Information Table 64. Shionogi Description and Business Overview Table 65. Shionogi Recombinant Human Thrombopoietin (rhTPO) Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021) Table 66. Shionogi Recombinant Human Thrombopoietin (rhTPO) Product Table 67. Shionogi Recent Developments/Updates Table 68. MedChemExpress Corporation Information Table 69. MedChemExpress Description and Business Overview Table 70. MedChemExpress Recombinant Human Thrombopoietin (rhTPO) Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021) Table 71. MedChemExpress Recombinant Human Thrombopoietin (rhTPO) Product Table 72. MedChemExpress Recent Developments/Updates Table 73. PeproTech Corporation Information Table 74. PeproTech Description and Business Overview Table 75. PeproTech Recombinant Human Thrombopoietin (rhTPO) Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021) Table 76. PeproTech Recombinant Human Thrombopoietin (rhTPO) Product Table 77. PeproTech Recent Developments/Updates Table 78. Kelun Corporation Information Table 79. Kelun Description and Business Overview Table 80. Kelun Recombinant Human Thrombopoietin (rhTPO) Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021) Table 81. Kelun Recombinant Human Thrombopoietin (rhTPO) Product Table 82. Kelun Recent Developments/Updates Table 83. Production Base and Market Concentration Rate of Raw Material Table 84. Key Suppliers of Raw Materials Table 85. Recombinant Human Thrombopoietin (rhTPO) Distributors List Table 86. Recombinant Human Thrombopoietin (rhTPO) Customers List Table 87. Recombinant Human Thrombopoietin (rhTPO) Market Trends Table 88. Recombinant Human Thrombopoietin (rhTPO) Growth Drivers Table 89. Recombinant Human Thrombopoietin (rhTPO) Market Challenges Table 90. Recombinant Human Thrombopoietin (rhTPO) Market Restraints Table 91. Global Recombinant Human Thrombopoietin (rhTPO) Sales Forecast by Type (2022-2027) & (KG) Table 92. Global Recombinant Human Thrombopoietin (rhTPO) Sales Market Share Forecast by Type (2022-2027) Table 93. Global Recombinant Human Thrombopoietin (rhTPO) Revenue Forecast by Type (2022-2027) & (US$ Million) Table 94. Global Recombinant Human Thrombopoietin (rhTPO) Revenue Market Share Forecast by Type (2022-2027) Table 95. Global Recombinant Human Thrombopoietin (rhTPO) Sales Forecast by Application (2022-2027) & (KG) Table 96. Global Recombinant Human Thrombopoietin (rhTPO) Sales Market Share Forecast by Application (2022-2027) Table 97. Global Recombinant Human Thrombopoietin (rhTPO) Revenue Forecast by Application (2022-2027) & (US$ Million) Table 98. Global Recombinant Human Thrombopoietin (rhTPO) Revenue Market Share Forecast by Application (2022-2027) Table 99. Global Recombinant Human Thrombopoietin (rhTPO) Sales Forecast by Region (2022-2027) & (KG) Table 100. Global Recombinant Human Thrombopoietin (rhTPO) Sales Market Share Forecast by Region (2022-2027) Table 101. Global Recombinant Human Thrombopoietin (rhTPO) Revenue Forecast by Region (2022-2027) & (US$ Million) Table 102. Global Recombinant Human Thrombopoietin (rhTPO) Revenue Market Share Forecast by Region (2022-2027) Table 103. Research Programs/Design for This Report Table 104. Key Data Information from Secondary Sources Table 105. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Recombinant Human Thrombopoietin (rhTPO) Figure 2. Global Recombinant Human Thrombopoietin (rhTPO) Market Share by Type in 2020 & 2027 Figure 3. rhTPO Product Picture Figure 4. Fusion Protein Product Picture Figure 5. Global Recombinant Human Thrombopoietin (rhTPO) Market Share by Application in 2020 & 2027 Figure 6. Medication Figure 7. Scientific Research Figure 8. Global Recombinant Human Thrombopoietin (rhTPO) Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 9. Global Recombinant Human Thrombopoietin (rhTPO) Market Size 2016-2027 (US$ Million) Figure 10. Global Recombinant Human Thrombopoietin (rhTPO) Sales 2016-2027 (KG) Figure 11. Global Recombinant Human Thrombopoietin (rhTPO) Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 12. Recombinant Human Thrombopoietin (rhTPO) Sales Share by Manufacturers in 2020 Figure 13. Global Recombinant Human Thrombopoietin (rhTPO) Revenue Share by Manufacturers in 2020 Figure 14. The Global 5 and 10 Largest Recombinant Human Thrombopoietin (rhTPO) Players: Market Share by Revenue in 2020 Figure 15. Recombinant Human Thrombopoietin (rhTPO) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 16. Global Recombinant Human Thrombopoietin (rhTPO) Sales Market Share by Region (2016-2021) Figure 17. Global Recombinant Human Thrombopoietin (rhTPO) Sales Market Share by Region in 2020 Figure 18. Global Recombinant Human Thrombopoietin (rhTPO) Revenue Market Share by Region (2016-2021) Figure 19. Global Recombinant Human Thrombopoietin (rhTPO) Revenue Market Share by Region in 2020 Figure 20. U.S. Recombinant Human Thrombopoietin (rhTPO) Revenue Growth Rate (2016-2021) (US$ Million) Figure 21. Canada Recombinant Human Thrombopoietin (rhTPO) Revenue Growth Rate (2016-2021) (US$ Million) Figure 22. Germany Recombinant Human Thrombopoietin (rhTPO) Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. France Recombinant Human Thrombopoietin (rhTPO) Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. U.K. Recombinant Human Thrombopoietin (rhTPO) Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. Italy Recombinant Human Thrombopoietin (rhTPO) Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Russia Recombinant Human Thrombopoietin (rhTPO) Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. China Recombinant Human Thrombopoietin (rhTPO) Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Japan Recombinant Human Thrombopoietin (rhTPO) Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. South Korea Recombinant Human Thrombopoietin (rhTPO) Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. India Recombinant Human Thrombopoietin (rhTPO) Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Australia Recombinant Human Thrombopoietin (rhTPO) Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Taiwan Recombinant Human Thrombopoietin (rhTPO) Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Indonesia Recombinant Human Thrombopoietin (rhTPO) Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Thailand Recombinant Human Thrombopoietin (rhTPO) Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Malaysia Recombinant Human Thrombopoietin (rhTPO) Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Philippines Recombinant Human Thrombopoietin (rhTPO) Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Vietnam Recombinant Human Thrombopoietin (rhTPO) Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Mexico Recombinant Human Thrombopoietin (rhTPO) Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Brazil Recombinant Human Thrombopoietin (rhTPO) Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Argentina Recombinant Human Thrombopoietin (rhTPO) Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Turkey Recombinant Human Thrombopoietin (rhTPO) Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Saudi Arabia Recombinant Human Thrombopoietin (rhTPO) Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. U.A.E Recombinant Human Thrombopoietin (rhTPO) Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Sales Market Share of Recombinant Human Thrombopoietin (rhTPO) by Type (2016-2021) Figure 45. Sales Market Share of Recombinant Human Thrombopoietin (rhTPO) by Application (2016-2021) Figure 46. Sales Market Share of Recombinant Human Thrombopoietin (rhTPO) by Application in 2020 Figure 47. Revenue Share of Recombinant Human Thrombopoietin (rhTPO) by Application (2016-2021) Figure 48. Revenue Share of Recombinant Human Thrombopoietin (rhTPO) by Application in 2020 Figure 49. Manufacturing Cost Structure of Recombinant Human Thrombopoietin (rhTPO) Figure 50. Manufacturing Process Analysis of Recombinant Human Thrombopoietin (rhTPO) Figure 51. Recombinant Human Thrombopoietin (rhTPO) Industrial Chain Analysis Figure 52. Channels of Distribution Figure 53. Distributors Profiles Figure 54. Bottom-up and Top-down Approaches for This Report Figure 55. Data Triangulation Figure 56. Key Executives Interviewed

1 Recombinant Human Thrombopoietin (rhTPO) Market Overview 1.1 Product Overview and Scope of Recombinant Human Thrombopoietin (rhTPO) 1.2 Recombinant Human Thrombopoietin (rhTPO) Segment by Type 1.2.1 Global Recombinant Human Thrombopoietin (rhTPO) Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 rhTPO 1.2.3 Fusion Protein 1.3 Recombinant Human Thrombopoietin (rhTPO) Segment by Application 1.3.1 Global Recombinant Human Thrombopoietin (rhTPO) Sales Comparison by Application: (2021-2027) 1.3.2 Medication 1.3.3 Scientific Research 1.4 Global Recombinant Human Thrombopoietin (rhTPO) Market Size Estimates and Forecasts 1.4.1 Global Recombinant Human Thrombopoietin (rhTPO) Revenue 2016-2027 1.4.2 Global Recombinant Human Thrombopoietin (rhTPO) Sales 2016-2027 1.4.3 Recombinant Human Thrombopoietin (rhTPO) Market Size by Region: 2016 Versus 2021 Versus 2027 2 Recombinant Human Thrombopoietin (rhTPO) Market Competition by Manufacturers 2.1 Global Recombinant Human Thrombopoietin (rhTPO) Sales Market Share by Manufacturers (2016-2021) 2.2 Global Recombinant Human Thrombopoietin (rhTPO) Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Recombinant Human Thrombopoietin (rhTPO) Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Recombinant Human Thrombopoietin (rhTPO) Manufacturing Sites, Area Served, Product Type 2.5 Recombinant Human Thrombopoietin (rhTPO) Market Competitive Situation and Trends 2.5.1 Recombinant Human Thrombopoietin (rhTPO) Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Recombinant Human Thrombopoietin (rhTPO) Players Market Share by Revenue 2.5.3 Global Recombinant Human Thrombopoietin (rhTPO) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Recombinant Human Thrombopoietin (rhTPO) Retrospective Market Scenario by Region 3.1 Global Recombinant Human Thrombopoietin (rhTPO) Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Recombinant Human Thrombopoietin (rhTPO) Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Recombinant Human Thrombopoietin (rhTPO) Market Facts & Figures by Country 3.3.1 North America Recombinant Human Thrombopoietin (rhTPO) Sales by Country 3.3.2 North America Recombinant Human Thrombopoietin (rhTPO) Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Recombinant Human Thrombopoietin (rhTPO) Market Facts & Figures by Country 3.4.1 Europe Recombinant Human Thrombopoietin (rhTPO) Sales by Country 3.4.2 Europe Recombinant Human Thrombopoietin (rhTPO) Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Recombinant Human Thrombopoietin (rhTPO) Market Facts & Figures by Region 3.5.1 Asia Pacific Recombinant Human Thrombopoietin (rhTPO) Sales by Region 3.5.2 Asia Pacific Recombinant Human Thrombopoietin (rhTPO) Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Recombinant Human Thrombopoietin (rhTPO) Market Facts & Figures by Country 3.6.1 Latin America Recombinant Human Thrombopoietin (rhTPO) Sales by Country 3.6.2 Latin America Recombinant Human Thrombopoietin (rhTPO) Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Recombinant Human Thrombopoietin (rhTPO) Market Facts & Figures by Country 3.7.1 Middle East and Africa Recombinant Human Thrombopoietin (rhTPO) Sales by Country 3.7.2 Middle East and Africa Recombinant Human Thrombopoietin (rhTPO) Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Recombinant Human Thrombopoietin (rhTPO) Historic Market Analysis by Type 4.1 Global Recombinant Human Thrombopoietin (rhTPO) Sales Market Share by Type (2016-2021) 4.2 Global Recombinant Human Thrombopoietin (rhTPO) Revenue Market Share by Type (2016-2021) 4.3 Global Recombinant Human Thrombopoietin (rhTPO) Price by Type (2016-2021) 5 Global Recombinant Human Thrombopoietin (rhTPO) Historic Market Analysis by Application 5.1 Global Recombinant Human Thrombopoietin (rhTPO) Sales Market Share by Application (2016-2021) 5.2 Global Recombinant Human Thrombopoietin (rhTPO) Revenue Market Share by Application (2016-2021) 5.3 Global Recombinant Human Thrombopoietin (rhTPO) Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Qilu Pharmaceutical 6.1.1 Qilu Pharmaceutical Corporation Information 6.1.2 Qilu Pharmaceutical Description and Business Overview 6.1.3 Qilu Pharmaceutical Recombinant Human Thrombopoietin (rhTPO) Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Qilu Pharmaceutical Recombinant Human Thrombopoietin (rhTPO) Product Portfolio 6.1.5 Qilu Pharmaceutical Recent Developments/Updates 6.2 R&D Systems 6.2.1 R&D Systems Corporation Information 6.2.2 R&D Systems Description and Business Overview 6.2.3 R&D Systems Recombinant Human Thrombopoietin (rhTPO) Sales, Revenue and Gross Margin (2016-2021) 6.2.4 R&D Systems Recombinant Human Thrombopoietin (rhTPO) Product Portfolio 6.2.5 R&D Systems Recent Developments/Updates 6.3 Merck 6.3.1 Merck Corporation Information 6.3.2 Merck Description and Business Overview 6.3.3 Merck Recombinant Human Thrombopoietin (rhTPO) Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Merck Recombinant Human Thrombopoietin (rhTPO) Product Portfolio 6.3.5 Merck Recent Developments/Updates 6.4 Shionogi 6.4.1 Shionogi Corporation Information 6.4.2 Shionogi Description and Business Overview 6.4.3 Shionogi Recombinant Human Thrombopoietin (rhTPO) Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Shionogi Recombinant Human Thrombopoietin (rhTPO) Product Portfolio 6.4.5 Shionogi Recent Developments/Updates 6.5 MedChemExpress 6.5.1 MedChemExpress Corporation Information 6.5.2 MedChemExpress Description and Business Overview 6.5.3 MedChemExpress Recombinant Human Thrombopoietin (rhTPO) Sales, Revenue and Gross Margin (2016-2021) 6.5.4 MedChemExpress Recombinant Human Thrombopoietin (rhTPO) Product Portfolio 6.5.5 MedChemExpress Recent Developments/Updates 6.6 PeproTech 6.6.1 PeproTech Corporation Information 6.6.2 PeproTech Description and Business Overview 6.6.3 PeproTech Recombinant Human Thrombopoietin (rhTPO) Sales, Revenue and Gross Margin (2016-2021) 6.6.4 PeproTech Recombinant Human Thrombopoietin (rhTPO) Product Portfolio 6.6.5 PeproTech Recent Developments/Updates 6.7 Kelun 6.6.1 Kelun Corporation Information 6.6.2 Kelun Description and Business Overview 6.6.3 Kelun Recombinant Human Thrombopoietin (rhTPO) Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Kelun Recombinant Human Thrombopoietin (rhTPO) Product Portfolio 6.7.5 Kelun Recent Developments/Updates 7 Recombinant Human Thrombopoietin (rhTPO) Manufacturing Cost Analysis 7.1 Recombinant Human Thrombopoietin (rhTPO) Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Recombinant Human Thrombopoietin (rhTPO) 7.4 Recombinant Human Thrombopoietin (rhTPO) Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Recombinant Human Thrombopoietin (rhTPO) Distributors List 8.3 Recombinant Human Thrombopoietin (rhTPO) Customers 9 Recombinant Human Thrombopoietin (rhTPO) Market Dynamics 9.1 Recombinant Human Thrombopoietin (rhTPO) Industry Trends 9.2 Recombinant Human Thrombopoietin (rhTPO) Growth Drivers 9.3 Recombinant Human Thrombopoietin (rhTPO) Market Challenges 9.4 Recombinant Human Thrombopoietin (rhTPO) Market Restraints 10 Global Market Forecast 10.1 Recombinant Human Thrombopoietin (rhTPO) Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Recombinant Human Thrombopoietin (rhTPO) by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Recombinant Human Thrombopoietin (rhTPO) by Type (2022-2027) 10.2 Recombinant Human Thrombopoietin (rhTPO) Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Recombinant Human Thrombopoietin (rhTPO) by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Recombinant Human Thrombopoietin (rhTPO) by Application (2022-2027) 10.3 Recombinant Human Thrombopoietin (rhTPO) Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Recombinant Human Thrombopoietin (rhTPO) by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Recombinant Human Thrombopoietin (rhTPO) by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer